• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Pharmaceuticals

Phillips Medisize fully integrates Vectura inhaled therapies into business

May 7, 2025 By Sean Whooley

Phillips Medisize Vectura

Phillips Medisize announced that it officially integrated Vectura into its business, expanding its capabilities in inhaled therapies. At the start of the year, the company completed its acquisition of Vectura from a subsidiary of cigarette maker Philip Morris. Vectura enables Phillips Medisize to offer a wider range of formulation, device design, combination product development and manufacturing […]

Filed Under: Business/Financial News, Drug-Device Combinations, Pharmaceuticals, Respiratory Tagged With: Phillips-Medisize, Vectura

Aptar reports positive adherence results with iPump dose software

April 14, 2025 By Sean Whooley

Aptar Digital health iPump (1) (1)

Aptar Digital Health today announced survey findings showcasing the impact of its iPump connected assistant for medication adherence. The SPEED survey looked at iPump’s effect on adherence to Stallergenes Greer’s sublingual liquid immunotherapy (SLIT). Stallergenes Greer will present findings at the CFA congress (Congrès Francophone d’Allergologie) in Paris this week. iPump, developed in conjunction with […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Patient Monitoring, Pharmaceuticals, Technology Tagged With: aptarpharma

Vaxess raises $9M to support drug delivery patch, GLP-1 work

April 9, 2025 By Sean Whooley

Vaxess Technologies MIMIX vaccine patch

Shelf-stable vaccine patch maker Vaxess Technologies announced today that it received an additional $9 million in funding. Participants in the latest funding round for Woburn, Massachusetts-based Vaxess included RA Capital Management and Engine Ventures. The company plans to use the funds to continue to advance its work in GLP-1 therapeutics and to expand manufacturing capabilities. It […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Funding Roundup, Pharmaceuticals Tagged With: Vaxess Technologies

Satio completes development, testing of remotely controllable, at-home intradermal drug delivery system

April 7, 2025 By Sean Whooley

Satio intradermal drug delivery system screenshot

Satio announced today that it completed a Small Business Innovation Research (SBIR) contract for its intradermal drug delivery system. The NIH’s Advanced Research Projects Agency for Health (ARPA-H) awarded Satio the $3.5 million in September 2023. This contract aimed to help the company develop SatioRx, its intradermal drug delivery device. The compact, inexpensive device features […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals, Technology Tagged With: Satio

Nasal vaccine devices: Design and regulatory need-to-knows

February 14, 2025 By Jim Hammerand

A photo of a nasal vaccine device spraying mist.

Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses. In 2024, the FDA approved a nasal spray as the first at-home influenza vaccination, allowing adults to vaccinate themselves or someone in their care without a needle jab or a trip to the pharmacy. Intranasal vaccines […]

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Pharmaceuticals, Regulatory/Compliance Tagged With: aptarpharma

Koru Medical inks deal to develop next-gen subcutaneous infusion system

February 7, 2025 By Sean Whooley

Koru Medical Systems

Koru Medical Systems (Nasdaq:KRMD) announced today that it signed a development agreement with a global pharmaceutical company. The agreement is intended for Koru to develop and seek regulatory clearance for a next-generation subcutaneous immunoglobulin (SCIg) therapy infusion system for use with a commercialized drug therapy. It also includes a close collaboration with Schott Pharma. Koru […]

Filed Under: Business/Financial News, Drug-Device Combinations, Pharmaceuticals Tagged With: Koru Medical Systems, Schott Pharma

Fractyl Health announces layoffs as it pivots to gene therapy

February 3, 2025 By Sean Whooley

This is the logo of Fractyl Health.

Fractyl Health (Nasdaq:GUTS) is cutting nearly a fifth of its workforce as it streamlines resources and shifts focus toward certain therapies. The company, which develops therapies and procedures for treating obesity and type 2 diabetes, said it plans to prioritize its REMAIN-1 pivotal study. This study addresses the demand for an off-ramp to GLP-1 therapies. […]

Filed Under: Business/Financial News, Diabetes, Featured, Pharmaceuticals Tagged With: Fractyl Health

Analysts say Embecta is ‘heading in the right direction’ following patch pump discontinuation

January 16, 2025 By Sean Whooley

BD Diabetes Spinoff Embecta

Analysts called a recent stock sell-off at Embecta (Nasdaq:EMBC) “unwarranted” and believe the company is moving in the right direction despite recent challenges. Late last year, Embecta filed with the state of Massachusetts to confirm a workforce reduction affecting 118 employees. This related to the company’s plans to discontinue its insulin patch pump program and restructure. […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Technology, Wall Street Beat Tagged With: embecta

Ypsomed, BD collab on self-injection systems for high-viscosity biologics

October 23, 2024 By Sean Whooley

BD NeoPak prefillable syringe Ypsomed YpsoMate auto-injector

BD (NYSE:BDX) and Ypsomed today announced a strategic collaboration to advance self-injection solutions for high-viscosity biologic drugs. In a joint project, the companies pre-assessed and streamlined the integration of the BD Neopak XtraFlow glass prefillable syringe with the Ypsomed YpsoMate 2.25 auto-injector platform. They aim to address current limitations by enabling the delivery of higher-viscosity […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Pharmaceuticals Tagged With: BD, Ypsomed

BD partners with ten23 health on prefilled syringe manufacturing

October 7, 2024 By Sean Whooley

BD ten23 Health RFID prefillable syringe manufacturing

BD (NYSE:BDX) announced today that it entered into a collaboration with ten23 health to develop a new way to track prefillable syringes (PFS). ten23 health, a Swiss CDMO, offers drug development, filling and device assembly expertise to contribute to the product offering. It recently entered into a production collaboration with on-body drug delivery device maker […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals, Technology Tagged With: BD, ten23 health

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 206
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS